Action against Koyilandy drug store that sold liquid glucose as COVID-19 prophylactic

Public health practitioner’s statement has misled people, says CAPSULE chairman

October 21, 2020 12:13 am | Updated 12:13 am IST - Kozhikode

The Drugs Control Department is expected to take action against a drug store in Koyilandy in Kozhikode district, after reports emerged that glucose in liquid form was being sold there apparently as a preventive drug for COVID-19.

According to K. Sujith Kumar, Assistant Drugs Controller, the shop was found to be selling liquid glucose in bottles. “A show-cause notice will be issued to the owner of the shop. Their licence could be suspended and the drug dispensing permission will be revoked,” he told The Hindu on Tuesday. Mr. Kumar said that they searched the shop after directions from the State Drugs Controller. It is learnt that the officials have warned other shops against its sale.

E. Sukumaran, a former Deputy Director of Health and a well-known public health practitioner from Koyilandy, had earlier claimed that 25% of glucose in liquid form could prevent SARS-CoV-2 infection if it is applied as nasal drops. A major newspaper published a report on this, quoting him. Later, Dr. Sukumaran also wrote an article in the same newspaper in defence of his claim. Public health activists pointed out that the sale of liquid glucose should be viewed against the backdrop of this statement.

Meanwhile, Campaign Against Pseudo Science Using Law and Ethics (CAPSULE), a platform of the Kerala Sasthra Sahithya Parishad, has filed a complaint with the Travancore-Cochin Medical Council, which is the registration body for doctors. CAPSULE chairman U. Nandakumar said that Dr. Sukumaran’s claim neither had any scientific basis nor the support of randomised-controlled trials, which are essential for the use of any drug. Liquid glucose was yet to be proved effective to counter COVID-19. The claim had already misled a section of the society and led to widespread discussion, he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.